CVRx

Update in progress

CVRX (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

CVRx, Inc. is a commercial‑stage medical device company that develops, manufactures, and markets neuromodulation therapies for cardiovascular diseases. Its flagship Barostim device is an implant that delivers electrical pulses to baroreceptors in the carotid artery to address impaired baroreceptor signaling and enable baroreflex activation therapy, linking the cardiovascular system to the autonomic nervous system. Products are sold through direct sales, agents, and distributors. Founded 2000; headquartered in Minneapolis.

Company score

Sentiment: 0.34; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.39; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.14; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.24; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive